Fauna Bio is a brand that focuses on extraordinary genomics for human health. With traditional drug discovery failing to find solutions for persistent health challenges such as heart disease, cancers, respiratory diseases, stroke, Alzheimer’s, and diabetes, Fauna Bio turns to functional genomics as a way forward. They take a broad approach within the animal kingdom, utilizing extreme adaptation common in many mammals to identify and understand the protective physiological mechanisms that enable their survival.

By doing so, Fauna Bio can rapidly develop novel treatments. With targets in pulmonary disease, heart failure, obesity, and neurodegeneration, they are addressing a potential market worth over $60 billion. Their platform includes the Biobank, evolutionary constraints, machine learning, contrast biologies, compound prediction, and therapeutics.

Fauna Bio's platform not only predicts new uses for small molecules, but it also identifies the best genes to target for diseases with high unmet need and offers a broad range of modalities for treatment. With their innovative approach, Fauna Bio is paving the way for breakthroughs in human health